Future Journal of Pharmaceutical Sciences

Table 9 Stability studies data of SLNs

From: Development, optimization, and in vitro evaluation of atorvastatin calcium and vinpocetine codelivery by solid lipid nanoparticles for cancer therapy

Months	4 °C refrigerated			RT
Months	Particle size (nm)*	EE ATS (%)*	EE VIN (%)*	Particle size (nm)*	EE ATS (%)*	EE VIN (%)*
0	323 ± 4	64.69 ± 0.6	65.98 ± 0.6	323 ± 6.3	64.69 ± 0.3	65.98 ± 0.5
1	329 ± 7.3	64.46 ± 0.7	65.75 ± 1.6	345 ± 5.4	64.28 ± 1.1	65.49 ± 0.7
2	347 ± 8.6	64.28 ± 1.2	65.51 ± 0.9	392 ± 6	63.77 ± 0.9	64.82 ± 1.1
3	354 ± 5.4	63.88 ± 0.8	65.16 ± 1.3	428 ± 9.5	62.92 ± 1.6	64.11 ± 0.9
6	383 ± 8.2	62.49 ± 0.6	64.49 ± 0.9	797 ± 15.4	60.58 ± 2.1	62.15 ± 1.6
Mean	347.2	63.96	64.51	457	63.25	65.38

RT, room temperature
*p < 0.05 value is insignificant

Back to article page